reports
Roblox Corp: 1 director
A director at Roblox Corp gave away/sold 89,584 shares at 0.000USD and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cl...
Flex Ltd: 1 director
A director at Flex Ltd sold 15,000 shares at 62.212USD and the significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showin...
360 Capital Group Limited: 1 director
A director at 360 Capital Group Limited bought 3,752,847 shares at 0.310AUD and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two...
Uber Technologies Inc: 1 director
A director at Uber Technologies Inc sold 5,500 shares at 94.406USD and the significance rating of the trade was 64/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cl...
Impinj Inc: 1 director
A director at Impinj Inc sold 30,000 shares at 155.630USD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sho...
nLIGHT Inc: 1 director
A director at nLIGHT Inc sold 12,560 shares at 35.330USD and the significance rating of the trade was 57/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly show...
Third Age Health Services Limited: 1 director
A director at Third Age Health Services Limited sold 30,848 shares at 5.045NZD and the significance rating of the trade was 71/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last ...
Capital Bancorp Inc: 1 director
A director at Capital Bancorp Inc sold 3,400 shares at 27.950USD and the significance rating of the trade was 61/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clea...
Box Inc: 2 directors
Two Directors at Box Inc sold 21,612 shares at between 31.350USD and 31.362USD. The significance rating of the trade was 58/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two...
StepStone Group Inc: 1 director
A director at StepStone Group Inc sold 211,210 shares at 62.121USD and the significance rating of the trade was 98/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cl...
Princeton Bancorp Inc: 2 directors
Two Directors at Princeton Bancorp Inc bought/sold 6,552 shares at between 32.620USD and 33.000USD. The significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directo...
Pinterest Inc: 1 director
A director at Pinterest Inc sold 74,047 shares at 26.887USD and the significance rating of the trade was 73/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly s...
Pennymac Financial Services Inc: 1 director
A director at Pennymac Financial Services Inc sold 5,000 shares at 129.264USD and the significance rating of the trade was 63/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last t...
ServiceTitan Inc: 1 director
A director at ServiceTitan Inc sold 32,776 shares at 92.275USD and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clear...
Datadog Inc: 2 directors
Two Directors at Datadog Inc sold 490,028 shares at between 197.988USD and 199.643USD. The significance rating of the trade was 80/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the l...
- Benjaphol Suthwanish
- Tanaporn Visaruthaphong
PTT Global Chemical (PTTGC TB) - Executes 2025 Plan As Targeted
Company Update | PTT Global Chemical (PTTGC TB/HOLD/Bt20.40/Target: Bt20.00) PTTGC successfully met its management-set targets in early-25. Supported by lower interest expenses, higher ethane feedstock utilisation, and reduced SG&A costs from Allnex, earnings are expected to improve noticeably in 2026. Although the olefins spread outlook remains weak, supply conditions are expected to ease during the year. We have revised down our 2026 earnings forecast but continue to anticipate a solid recover...
Fennec Pharmaceuticals Announces Private Offering of Common Shares in ...
Fennec Pharmaceuticals Announces Private Offering of Common Shares in Canada RESEARCH TRIANGLE PARK, N.C., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC) (TSX:FRX) (“Fennec” or the “Company”), a specialty pharmaceutical company, today announced that it intends to engage in a non-brokered offering of its common shares in Canada, at a price of US$7.50 per share, with certain of its existing institutional shareholders, for aggregate gross proceeds of up to US$5,025,000. The offering is expected to close on November 17, 2025, subject to the Company entering into s...
- Benjaphol Suthwanish
Bangkok Dusit Medical Services (BDMS TB) - Strong 4Q25 Awaits
Company Update | Bangkok Dusit Medical Services (BDMS TB/BUY/Bt19.70/Target: Bt32.00) The tone at BDMS’ analyst meeting tone was positive, with management maintaining a strong outlook for 4Q25 supported by the ongoing influenza outbreak. Influenza cases surged 44.9% yoy in Week 45, boosting Thai patient revenue by 8% yoy in Oct 25. 3Q25 net profit came in at Bt4.3b (+1.7% yoy), beating consensus by 5%. While the Ministry of Commerce’s new measure may slightly affect top-line, BDMS plans to mitig...
- Tanapon Cholkadidamrongkul
Plan B Media (PLANB TB) - 3Q25: Earnings In Line; Waiting For High Sea...
Company Results | Plan B Media (PLANB TB/BUY/Bt4.10/Target: Bt6.20) PLANB reported a 3Q25 net profit of Bt290m (3% yoy, +8% qoq). Earnings grew yoy and qoq despite the sluggish economic environment. Looking ahead, we expect PLANB’s performance to continue improving in 4Q25, supported by the seasonal peak in media spending. Maintain BUY with a target price of Bt6.20
Fennec Pharmaceuticals Announces Pricing of Offering of Common Shares
Fennec Pharmaceuticals Announces Pricing of Offering of Common Shares RESEARCH TRIANGLE PARK, N.C., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC) (TSX:FRX) (“Fennec” or the “Company”), a specialty pharmaceutical company, today announced the pricing of its underwritten registered public offering of 4,666,667 common shares at a public offering price of $7.50 per share. In addition, Fennec has granted the underwriters a 30-day option to purchase up to an additional 700,000 common shares on the same terms and conditions. Fennec anticipates the total gross proceed...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.